Similar articles for PMID: 10021913

Year	Number of Results
1988	1
1992	1
1994	2
1995	1
1997	2
1998	6
1999	9
2000	5
2001	14
2002	6
2003	6
2004	1
2005	6
2006	4
2007	5
2008	1
2009	4
2010	1
2011	2
2012	3
2013	3
2014	4
2015	2
2016	1
2017	7
2018	3
2019	4
2020	2
2021	2
2022	3
2024	0

1

Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket.

Reiter LA, Rizzi JP, Pandit J, Lasut MJ, McGahee SM, Parikh VD, Blake JF, Danley DE, Laird ER, Lopez-Anaya A, Lopresti-Morrow LL, Mansour MN, Martinelli GJ, Mitchell PG, Owens BS, Pauly TA, Reeves LM, Schulte GK, Yocum SA. Reiter LA, et al. Bioorg Med Chem Lett. 1999 Jan 18;9(2):127-32. doi: 10.1016/s0960-894x(98)00729-x. Bioorg Med Chem Lett. 1999. PMID: 10021913

2

Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.

Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD. Reiter LA, et al. Bioorg Med Chem Lett. 2003 Jul 21;13(14):2331-6. doi: 10.1016/s0960-894x(03)00413-x. Bioorg Med Chem Lett. 2003. PMID: 12824028

3

Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors.

Lovejoy B, Welch AR, Carr S, Luong C, Broka C, Hendricks RT, Campbell JA, Walker KA, Martin R, Van Wart H, Browner MF. Lovejoy B, et al. Nat Struct Biol. 1999 Mar;6(3):217-21. doi: 10.1038/6657. Nat Struct Biol. 1999. PMID: 10074939

4

Structural basis for the highly selective inhibition of MMP-13.

Engel CK, Pirard B, Schimanski S, Kirsch R, Habermann J, Klingler O, Schlotte V, Weithmann KU, Wendt KU. Engel CK, et al. Chem Biol. 2005 Feb;12(2):181-9. doi: 10.1016/j.chembiol.2004.11.014. Chem Biol. 2005. PMID: 15734645

5

Virtual High-Throughput Screening for Matrix Metalloproteinase Inhibitors.

Choi JY, Fuerst R. Choi JY, et al. Methods Mol Biol. 2017;1579:259-271. doi: 10.1007/978-1-4939-6863-3_14. Methods Mol Biol. 2017. PMID: 28299742 Free PMC article.

6

Heterocycle-based MMP inhibitors with P2' substituents.

Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE. Pikul S, et al. Bioorg Med Chem Lett. 2001 Apr 23;11(8):1009-13. doi: 10.1016/s0960-894x(01)00137-8. Bioorg Med Chem Lett. 2001. PMID: 11327577

7

Tetrahydroisoquinoline-3-carboxylate based matrix-metalloproteinase inhibitors: design, synthesis and structure-activity relationship.

Matter H, Schudok M, Schwab W, Thorwart W, Barbier D, Billen G, Haase B, Neises B, Weithmann K, Wollmann T. Matter H, et al. Bioorg Med Chem. 2002 Nov;10(11):3529-44. doi: 10.1016/s0968-0896(02)00215-8. Bioorg Med Chem. 2002. PMID: 12213468

8

The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling.

Park HI, Jin Y, Hurst DR, Monroe CA, Lee S, Schwartz MA, Sang QX. Park HI, et al. J Biol Chem. 2003 Dec 19;278(51):51646-53. doi: 10.1074/jbc.M310109200. Epub 2003 Oct 7. J Biol Chem. 2003. PMID: 14532275 Free article.

9

X-ray structure of a novel matrix metalloproteinase inhibitor complexed to stromelysin.

Dunten P, Kammlott U, Crowther R, Levin W, Foley LH, Wang P, Palermo R. Dunten P, et al. Protein Sci. 2001 May;10(5):923-6. doi: 10.1110/ps.48401. Protein Sci. 2001. PMID: 11316871 Free PMC article.

10

High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.

Moy FJ, Chanda PK, Chen JM, Cosmi S, Edris W, Levin JI, Powers R. Moy FJ, et al. J Mol Biol. 2000 Sep 22;302(3):671-89. doi: 10.1006/jmbi.2000.4082. J Mol Biol. 2000. PMID: 10986126

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

106 results

Results by year